Azlocillin demonstrated high efficacy and safety in treating serious infections, particularly those caused by Pseudomonas aeruginosa. Clinical studies in North America and Europe confirmed its effectiveness, with low toxicity and good patient response rates.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: